Marwan Cheng Kuang Kwok

Dr Marwan Kwok is a National Institute for Health Research (NIHR) funded clinical lecturer. He is also a specialist registrar in haematology at Queen Elizabeth Hospital Birmingham. He is a member of the Royal College of Physicians and a fellow of the Royal College of Pathologists. He held a Leukaemia and Lymphoma Research clinical research fellowship from 2014 to 2017 during which he completed doctoral research training under the mentorship of Professor Tatjana Stankovic and Professor Peter Hillmen.

His current research focuses on lymphoid malignancies, particularly chronic lymphocytic leukaemia. His research interests include the natural history and clinical heterogeneity of lymphoid malignancies, as well as novel therapeutic targets and minimal residual disease in these conditions. He has authored manuscripts in New England Journal of Medicine, Blood and Leukemia. He was an EHA-ASH Translational Research Training in Hematology (TRTH) 2015 participant, and a past recipient of the UK CLL Forum Hamblin Prize (2016, 2020) and the Royal College of Pathologists specialty research medal (March 2017). 

Dr Kwok’s research is conducted within the Institute of Cancer and Genomic Sciences at the University of Birmingham, and at the Centre for Clinical Haematology at Queen Elizabeth Hospital. The research is carried out in close collaboration with the Haematological Malignancy Diagnostic Service in Leeds, and with the Centre for Computational Biology in Birmingham. The focus is on translational research with the aim to improve clinical outcome through novel insights into disease biology and therapeutics. Current research themes are as follows: 

1. Natural history and clinical heterogeneity of lymphoid malignancies

2. Novel therapeutic approaches for haematological malignancies and mechanisms of therapeutic resistance

3. Minimal residual disease in lymphoid malignancies